PDA Letter Article

Biologics Packaging Presents Risks

by Alessandro Morandotti, Ompi

Syringes

Biological drugs are growing in tandem with an aging, longer-living population. At the same time, biological drugs are very challenging to stabilize and administer due to their larger dosage and complexity, sensitivity and viscosity. Risks include extractables, glass delamination, particles and siliconization. But new prefilled syringe packaging options offer potential solutions to these risks.